MAGINJECTABLE 0.8 %, solution for injection 10 ampoules of 10 ml
Active ingredients: Magnesium pidolate
Commercialized according to BDPM
Solution for injection10 ampoules of 10 mlintramusculaire;intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- MAGINJECTABLE 0,8 POUR CENT, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intramusculaire;intraveineuse
- Presentation description
- 10 ampoule(s) en verre de 10 ml
- Marketing authorisation holder
- COOPER (ABRÉGÉ DE COOPERATION PHARMACEUTIQUE FRANCAISE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 11 Oct 2019
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64126741CIP73223462CIP133400932234622Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MAGNÉSIUM (PIDOLATE DE)solution | 10 g · 100 ml de solution injectable | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.